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may result.8-10 No study has quantitated total intraopera-
tive and postoperative use of blood products in TAAAs.
Problems with large transfusion requirements and coagu-
lopathy are amplified in patients with ruptured aneurysms
and possibly ameliorated by acute normovolemic hemodi-
lution (ANH).11 This technique involves intraoperative
large-volume phlebotomy with reinfusion of crystalloid or
colloid before cross-clamping: the phlebotomized fresh
autologous whole blood is stored for reinfusion at the end
of the procedure.
The purpose of this work is to identify preexisting coag-
ulation abnormalities in patients with thoracic and thora-
coabdominal aneurysm compared with matched control
subjects without aneurysms. We describe the blood product
use for this surgery and document that near-normal post-
operative coagulation parameters may be obtained.
PATIENTS AND METHODS
This is a single-center prospective consecutive cohort
study: inclusion criteria were patients with thoracoabdom-
inal aneurysms who underwent operation either electively
or for rupture by a single surgical/anesthetic team
between 1990 and 1995. Patients with dissections or trau-
matic rupture were not included. Patients provided
Coagulation disorders represent an important aspect
of the management of patients with thoracoabdominal
aortic aneurysms (TAAAs). A number of case reports of
disseminated intravascular coagulopathy (DIC) associated
with aortic dissection,1 TAAA,2 and abdominal aortic
aneurysms (AAAs)3-6 have appeared, together with case
series suggesting that milder coagulation disturbances may
be relatively common in these populations.2,6,7 Pre-
operative coagulation abnormalities identifiable with rou-
tine laboratory investigations in patients with TAAAs have
not previously been described.
Surgery for this condition is associated with major
blood loss necessitating large volume transfusion, and
complex intraoperative and postoperative coagulopathy
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Objectives: We sought to study the hemostatic profile and the use of blood products in patients undergoing thoracic and
thoracoabdominal aortic aneurysm repair.
Methods: This is a cohort study comparing three groups of patients: 7 undergoing elective acute normovolemic hemo-
dilution (ANH); 15 undergoing elective procedures without ANH (non-ANH); and 8 undergoing repair of ruptured
thoracoabdominal aneurysms. A control group of 10 patients was used for comparison of preoperative hemostasis. The
parameters studied were platelet concentration, partial thromboplastin time (PTT), and international normalized ratio
(before and after surgery), packed red blood cells, fresh frozen plasma, platelets, cryoprecipitates, donor exposure, and
use of desmopressin and epsilon-aminocaproic acid. Analysis of variance and multiple stepwise regression analysis were
used.
Results: Before operation the patients with aneurysms had PTTs prolonged compared with control subjects (P < .05).
After operation the ANH group had higher platelet counts than the ruptured group (P = .001) and higher platelet
counts (P = .05) and lower PTTs (P = .001) than the non-ANH group. The ANH group was transfused fewer platelets
than the non-ANH group (P = .001) and less of every blood product than the ruptured group (P = .05); statistically
significant differences were not observed for packed red blood cells, fresh frozen plasma, or platelets. The ANH group
was exposed to an average of 65 donors fewer than the ruptured group (P < .001) and 34 fewer than the non-ANH
group (P < .05). These differences could not be explained by baseline coagulation status or by the intraoperative use
of desmopressin or epsilon-aminocaproic acid.
Conclusions: The coagulation abnormality identified before surgery is that of higher PTT values, suggesting a distur-
bance of the extrinsic coagulation pathway. Blood losses, donor exposure, and platelet use were highest in the ruptured
group and lowest in the ANH group. After surgery the ruptured group exhibited the worst coagulation parameters,
and the ANH group exhibited the best with higher platelet count and lower PTT values than the other groups. The
ANH technique appears to be an useful adjunct in the anesthetic management of these patients. (J Vasc Surg
2001;33:462-8.)
informed consent for surgery and ANH; data were col-
lected prospectively. Twenty-two patients underwent elec-
tive procedures, of whom 15 (before 1993) were managed
with standard anesthetic technique (non-ANH), and
seven (after 1993) with acute normovolemic hemodilu-
tion (ANH). An additional group of eight patients under-
went emergency surgery for ruptured TAAAs. A control
group for comparison of preoperative coagulation param-
eters comprised 10 consecutive patients undergoing
carotid endarterectomy who were not receiving anticoag-
ulants, had no clinical evidence of aneurysmal disease, and
whose abdominal aorta did not exceed 3 cm in maximum
diameter by ultrasound scanning. These were thought to
represent patients similar in age and nonaneurysmal vas-
cular disease to the population with aneurysms described.
Patients with TAAAs were classified in four groups
according to Svensson and Crawford.12 Distal arch
aneurysms are defined as aneurysms involving and local-
ized to that segment of the aortic arch from which the left
subclavian artery arises.
Surgical techniques. All patients, including emer-
gency cases, underwent standard general anesthesia with a
left-sided double-lumen endotracheal tube. One or two
arterial lines were inserted, followed by a pulmonary artery
catheter and three large-bore central venous lines. Patients
underwent operation with Crawford’s “clamp and sew”
technique, with mild general hypothermia, no cell-saver
device, and no systemic administration of heparin. In
patients with group I and group II TAAAs undergoing
elective procedures, a catheter was placed in the subarach-
noid space for drainage and pressure monitoring.
Transfusion practices. Hemoglobin concentration,
hematocrit, prothrombin time (PT), partial thromboplas-
tin time (PTT), and platelet concentration were deter-
mined before induction and at frequent intervals during
the case. All fluids were administered through a blood
warmer, with the object of keeping the patient mildly
hypothermic at a temperature above 34°C throughout the
cases (monitored by nasopharyngeal probe). Ringer’s lac-
tate was the preferred solution for crystalloid infusion and
was administered at a rate of 12 mL/kg/h with the objec-
tive of keeping the total infusion less than 8 L. Normal
saline solution was used to flush infusion lines for blood
products, resulting in an additional volume infusion of 1
to 3 L; in addition, approximately 1 L of 5% albumin was
also used in each patient. Stored packed red blood cells
(PRCs) were transfused when the hematocrit was less than
30% or the hemoglobin concentration was less than 100
g/L. In the context of hypotension or observed brisk
bleeding, blood was transfused replacing estimated losses,
volume by volume. Fresh frozen plasma (FFP) was infused
as volume replacement (ie, according to visual estimates of
volume loss and measured central pressures), with a ratio
1:1 with PRC and, when volume status permitted, to nor-
malize the internal normalized ratio (INR) and PTT. The
ratio of PRC to FFP was adjusted to keep the hematocrit
greater than or equal to 30%. When the intravascular vol-
ume did not allow transfusion of FFP, cryoprecipitate was
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given to correct coagulation abnormalities. Platelets were
transfused when the platelet count was less than 100 ×
109/L. Epsilon-aminocaproic acid and desmopressin were
used only when coagulation abnormalities persisted in the
face of the aggressive replacement of coagulation factors
described above. This transfusion strategy was used con-
sistently for all patient groups.
ANH technique. A modification11 of the standard
ANH technique13-16 was used. Phlebotomy was initiated
soon after the patient was positioned on the operating table.
During this phase, each liter of the patient’s blood was
replaced with an equal volume of 5% albumin. Generally
about 1 L was removed, the goal being to lower the
patient’s hemoglobin concentration to approximately 100
g/L (hemodilution phase). Phlebotomy was then contin-
ued until another 1 to 1.5 L was obtained. During this
phase, each liter of autologous blood was replaced with 600
mL stored PRC and 400 mL 5% albumin (partial exchange
transfusion). Immediately before the proximal aorta was
clamped, an additional 450 to 750 mL of autologous blood
was removed from the patient without volume replacement.
The reinfusion of autologous blood was started after the
surgeon began the distal aortic anastomosis.
Postoperative care. After operation patients from all
groups were transferred to the intensive care unit, where
they were cared for according to standard practice by
physicians who were unaware of the research group’s
interest in transfusion requirements. Prospective data on
all blood products transfused were collected for the entire
intensive care unit and in-hospital stay.
Study procedure. Before operation patients were ques-
tioned about and examined for evidence of spontaneous
bruising or petechiae. Hemoglobin, platelet count, INR,
and PTT were determined before operation and at the
point of arrival in the intensive care unit after operation.
Blood losses were estimated from the blood in the suction
containers and the weight of saturated sponges. The intra-
operative and postoperative use of blood products, desmo-
pressin, and epsilon-aminocaproic acid was recorded.
Statistical analysis. Data were analyzed with
BMDP–7.0 (SPSS Inc, Chicago, Ill). Univariate and mul-
tivariate analysis of variance and multiple stepwise regres-
sion analysis were used. Post hoc comparisons were made
by use of Tukey’s studentized range method. For contin-
uous variables all data are expressed as mean ± SD.
We hypothesized that group I, group IV, and distal
arch aneurysms would represent aneurysms with lower
risk of blood loss and that this risk would be higher for
group II and group III aneurysms. Because the size of this
data set did not permit the examination of each group as
a separate variable, we investigated this hypothesis by col-
lapsing the classification into two strata, putative high
transfusion risk (group II and III) and low transfusion risk
(group I, group IV, and distal arch aneurysms).
RESULTS
Twenty-six of the 30 patients were men. The average
age was 69 ± 10 years. Patients with ruptured aneurysms
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were older than patients undergoing elective procedures,
but differences were not statistically significant. The
demographics, aneurysm type, and comorbidity are sum-
marized in Table I. No patients was taking antiplatelet or
anticoagulant medications during the week before surgery.
Three patients in the elective group and six in the rup-
tured group died before discharge. In the remaining 21
patients, the 1-year survival rate was 89%. Two patients
had paraplegia, one in the elective group and one in the
ruptured group, both with group II TAAAs, and both of
them died of respiratory complications and kidney failure.
No patients had a history of easy bruising or physical
evidence of petechiae, and none had thrombocytopenia.
Descriptive statistics of preoperative hemoglobin concen-
tration and coagulation parameters are summarized in
Table II. Preoperative hemoglobin, INR, PTT, and
platelet count differed among the three groups (ruptured,
electively repaired aneurysms, and control subjects) by
multivariate analysis of variance (P < .05). The presence of
an aneurysm, and whether it was ruptured, accounted for
52% of the observed variance in these parameters (η2 =
0.52). PTT was significantly prolonged in patients with
aneurysms compared with controls (mean difference 4.5
seconds, 95% CI 0.5-9.0 seconds; post hoc t test, P < .05).
Hemoglobin levels were lower in the ruptured aneurysm
group than in patients with elective aneurysms or non-
aneurysmal control subjects (mean difference 33 g/L,
95% CI 16-62 g/L; post hoc t test, P < .001). Within the
Table I. Demographics
Control TAAAs
Elective Ruptured
ANH Non-ANH
Total 10 7 15 8
Sex (female, n) 3 0 3 1
Age (y) 70.3 ± 7.9 63.6 ± 175 71.4 ± 6.4 74.2 ± 3.6
TAAA Group I, n 1 –– 1
TAAA Group II, n 1 1 1
TAAA Group III, n 2 3 1
TAAA Group IV, n 2 9 5
Distal arch aneurysm, n 1 2 ––
Visceral ischemia (min) 53 ± 15 45 ± 22 40 ± 20
Comorbidity
Hypertension, n (%) 7 (70) 6 (86) 10 (66) 6 (75)
Peripheral vascular disease, n (%) 4 (40) 3 (42) 6 (40) 2 (25)
Coronary artery disease, n (%) 7 (70) 2 (30) 6 (40) 5 (62)
Chronic obstructive lung disease, n (%) 3 (30) 2 (30) 6 (20) 4 (50)
Cerebrovascular accident n (%) 9 (90) –– 3 (20) 2 (25)
Diabetes mellitus, n (%) 3 (30) 2 (29) 1 (7) 0 (0)
Creatinine level > 120 µmol/L, n (%) 1 (10) 1 (14) 5 (33) 7 (87)
Table II. Coagulation parameters and estimated blood loss
Controls All aneurysms Elective aneurysms Ruptured aneurysms
ANH Non-ANH
Preoperative
Hemoglobin (g/L) 127 ± 11 132 ± 16 134 ± 12 131 ± 4 99 ± 9
INR 1.1 ± 0.1 1.1 ± 0.2 1.1 ± 0.2 1.1 ± 0.1 1.1 ± 0.1
PTT (s) 25 ± 5* 29 ± 4* 27 ± 3* 30 ± 1* 30 ± 1*
Platelets (109/L) 233 ± 70 258 ± 88 225 ± 40 273 ± 101 319 ± 102
Estimated blood loss (L) 5.8 ± 2.0 5.5 ± 1.5 6.1 ± 2.3 6.6 ± 2.2
Postoperative
Hemoglobin (g/L) 117 ± 11† 119 ± 16† 116 ± 9† 108 ± 6†
INR 1.2 ± 0.1 1.2 ± 0.1 1.2 ± 0.1 1.2 ± 0.1
PTT (s) 31 ± 6 26 ± 2 34 ± 5 40 ± 2
Platelets (109/L) 181 ± 63 218 ± 70 169 ± 14 135 ± 22
*Significant difference between controls and patients with aneurysms (P < .05).
†Significant difference between the ruptured group compared with either the nonruptured group or nonaneurysmal control (P < .001).
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elective group of patients, preoperative hemoglobin, INR,
PTT, and platelet count did not differ between patients
subsequently treated with or without ANH.
Table II summarizes the estimated intraoperative
blood loss, and the postoperative hemoglobin level and
coagulation parameters. The estimated intraoperative
blood loss was lower in the ANH group, but the differ-
ence did not achieve statistical significance (P = .40).
There were significant differences in postoperative
hemoglobin, INR, PTT, and platelet count among the
three groups, ANH, non-ANH, and ruptured. Group
membership (ANH, non-ANH, or ruptured) accounted
for 80% of the variance in these parameters (η2 = 0.80).
The extent of TAAAs (group I, group IV, and distal arch
aneurysms vs group II and III) was not a significant pre-
dictor of postoperative parameters. Statistically significant
differences between groups were confined to the platelet
count and PTT. Postoperative platelet count was lower in
the ruptured (P = .001) and non-ANH (P = .05) groups
compared with the ANH group. PTT was more pro-
longed in the non-ANH group compared with the ANH
(P = .001).
Visceral ischemia time was not significantly different
between the ANH group and non-ANH group (P = .60)
or between the ruptured and elective group (P = .53)
(Table I). Four patients in the ruptured group (50%), four
in the non-ANH (26%), and none in the ANH group
received desmopressin or epsilon-aminocaproic acid.
The total (intraoperative and postoperative) use of
PRC, FFP, platelets, and cryoprecipitate was significantly
different among the groups, ruptured, non-ANH, and
ANH, with group accounting for 64% of the variance in
the number of units of blood products used (η2 = 0.64, P
= .001). This analysis was adjusted for extent of TAAA
(group I, group IV, and distal arch aneurysms vs group II
and III), which was also found to be predictive of patterns
of blood product use. Transfusion practices for both indi-
vidual and total blood products are summarized in Table
III. The ANH group received no cryoprecipitate, fewer
platelets than the non-ANH group (P < .01), and less of
every blood product than the ruptured group (P < .05).
The non-ANH group received fewer units of cryoprecipi-
tate than the ruptured group, but statistically significant
differences were not observed between these two groups
for PRC, FFP, or platelets. Fig 1 is a graphical summary of
intraoperative and postoperative blood product transfu-
sion. Similar results were obtained when these time peri-
ods were analyzed separately. For the total hospital stay,
the mean transfusion requirements across all groups was
63 ± 39 units (median 53 units). During operation, the
mean blood products use was 44 ± 23 units (median 40
units).
In a separate analysis, we used stepwise linear regres-
sion to examine the relationship between the total number
of units of blood products transfused (the sum of PRC,
FFP, platelets, cryoprecipitate for each patient), and esti-
mated blood loss, TAAA group (ruptured vs elective ANH
vs elective non-ANH) and the extent of the aneurysm
(group I, group IV, and distal arch aneurysms vs group II
and III). Each of these variables proved statistically signif-
icant (P < .05). On average, compared with the ruptured
group, patients in the ANH group were transfused 65
fewer units, and in the non-ANH group 31 fewer units
(Fig 2). Among the patients in the elective group, the
non-ANH group was transfused 34 units more than the
ANH. Unsurprisingly, the number of units transfused
increases with estimated blood losses (5 units transfused
for each additional liter lost). The extent of the aneurysm
was again shown to affect the total transfusion, with
patients with group II and III receiving on average 27
units more than those with group I, group IV, and distal
arch aneurysms. Overall these clinical factors accounted
for 69% of the variance in total units of blood products
transfused (R2 = 0.69).
DISCUSSION
Occasional patients in whom DIC coexists with elec-
tive3,4 and ruptured AAAs5,6 and elective TAAAs2 have
long been recognized. These case reports and case series
do not permit the incidence of the problem to be esti-
mated. However, the prospective study of Fisher et al2
describes frank DIC in three of 32 thoracoabdominal and
none of 44 abdominal aortic aneurysms. Isolated elevation
of fibrin degradation products (FDP) without clinical
bleeding or depressed platelet counts was noted before
operation in 14% of TAAA and 8% of infrarenal AAA, sug-
gesting that a compensated process occurs in some of
these patients. In a series of 84 patients with ruptured and
Table III. Total blood products transfused 
Non-ANH ANH Ruptured
Packed red cells, U 17.8 ± 8 12.8 ± 6.9* 28.4 ± 13*
Platelets, U 22 ± 8† 8 ± 4† 25 ± 10†
Fresh frozen plasma, U 16.8 ± 8 11 ± 4* 23 ± 12*
Cryoprecipitate, U 13 ± 13‡ 0‡ 24 ± 23‡
Total, U 68 ± 29‡ 30 ± 12‡ 100 ± 43‡
*Significant difference between the ANH group and the ruptured group (P < .05).
†Significant difference between the ruptured group compared with either the ANH or non-ANH groups (P < .01).
‡Significant difference between the ruptured group compared with either the ANH or non-ANH groups (P < .05).
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unruptured AAA reported by Getaz et al,6 none had clin-
ical evidence of DIC. Similarly, in our series of 30 rup-
tured and unruptured TAAAs, no overt DIC was noted
before operation.
Of the patients with ruptured aneurysms reported by
Getaz et al,6 50% had platelet counts less than 150 × 109/L
and 56% coagulopathy. In the same study, 28% 
of patients with unruptured aneurysms had thrombocy-
topenia. However, only 67% of ruptured and 18% of
unruptured aneurysms had the relevant laboratory deter-
minations, and this may have led to overestimation of the
incidence of abnormalities. In a series of patients with aor-
tic disease undergoing elective procedures7 a 3% incidence
of preoperative abnormalities in PT and PTT was reported,
and no patient had abnormal levels of platelets or fibrino-
gen. The inclusion in this report of a number of patients
with nonaneurysmal disease likely results in underestima-
tion of the incidence of coagulation abnormalities. Another
small series of electively treated AAA17 found entirely nor-
mal PT, PTT, and thrombin clotting time in these patients.
In contrast, in a larger series of ruptured AAA,18 16 of 43
patients had prolongation of INR and the same proportion
thrombocytopenia. In our series no patient with electively
treated or ruptured aneurysm had a platelet count less than
150 × 109/L, 2 of 22 electively treated and 1 of 8 ruptured
had PT prolongation (> 1.2 seconds), and 3 of 22 elec-
tively treated and no patient with a ruptured aneurysm 
had PTT prolongation (> 34 seconds). Our finding of a
subtle preoperative prolongation in PTT compared with
control subjects would be consistent with mild consump-
tion coagulopathy, but our work is limited by the lack of
more sensitive markers of coagulation and fibrinolysis.
Abnormalities sufficient to cause frank thrombocytopenia
or clinically important prolongation of clotting parameters
are rare in elective AAAs or TAAAs, but may be more com-
mon in ruptured aneurysms.
Other studies have reported more subtle disturbances
in coagulation. A report of 20 consecutive patients with
Fig 1. Utilization of blood products. Plt, Platelets; Cryo, cryoprecipitate.
Fig 2. Relationship between total blood products transfused and estimated blood losses for each of three TAAA groups.
Regression lines are for each group analyzed separately. Slopes of lines are not significantly different one from another.
TAAAs or thoracic dissection found levels of anti-thrombin
III, FDP, thrombin-antithrombin III complex and plasmin-
alpha 2 plasmin inhibitor to be elevated before operation,
with normal levels of fibrinogen.9 Very similar results have
been obtained in AAAs, with the additional documenta-
tion of normal clotting parameters by routine testing.10
Gertler et al19 reported that in TAAAs, clotting factors
and fibrinogen levels decreased whereas D-dimer and pro-
thrombin fragment F1.2 increased 30 minutes after
supraceliac aortic cross-clamping, suggesting that mesen-
teric ischemia is responsible for coagulation factor con-
sumption and increased fibrinolytic activity during TAAAs
repair. Renal and limb ischemia also likely contribute: Illig
et al20 found normal hemostatic parameters before surgery
except for elevation in D-dimer, and that both FDP and
D-dimer increased after cross-clamping compared with
patients with infrarenal aneurysms. The increase in FDP
was significantly more pronounced in the group undergo-
ing supraceliac clamping. In our work the visceral ischemia
time was not different between groups and is unlikely to
account for the observed differences in coagulation parame-
ters and blood product use. With standard tests, there was no
significant correlation between the duration of visceral
ischemia and the extent of postoperative coagulation abnor-
malities, or with the total number of units of blood products
transfused (data not shown).
The clinical implications of these findings are
restricted to the most extreme cases. In ruptured AAA,
thrombocytopenia and prolongation of the INR have
been shown to be statistically significant multivariate pre-
dictors of death.18 With an aggressive blood product
transfusion strategy, relatively normal postoperative coag-
ulation parameters may be obtained.
Svensson et al21 reported the median number of units
of blood and blood products used during surgery in
Crawford’s experience from 1960 to 1991 in 1509
patients who underwent operation for TAAA with the use
of a cell saver: PRC 7 units (range, 1-46), FFP 16 units
(range, 0-132), platelets 20 units (range, 0-110), cryopre-
cipitate 0 unit (0-100), and autotransfused cells 8 units
(range, 0-68). In the latter part of this series, most patients
prophylactically received aminocaproic acid. The median
number of intraoperative blood products transfused was
51 units. Median intraoperative blood products transfu-
sion in our study was 40 units, even though a cell saver
device was not used.
Godet et al22 described the use of blood products in
33 patients undergoing TAAA repair. A strategy of avoid-
ing transfusion of blood products (PRC, FFP, and
platelets) unless indicated by hematocrit or abnormal
coagulation parameters was used. In the absence of the
results of appropriate tests, transfusions were given only
after clinically manifest coagulopathy had developed. In
this series the utilization of FFP was 8 ± 7 units, PRC 9 ±
6 units, autotransfused cells 12 ± 9 units. The mean blood
products transfused during surgery was 29 units. Eight
patients in this series had development of clinically signif-
icant intraoperative hemorrhagic complications not attrib-
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utable to surgical techniques, and three of these patients
died during surgery.
We have documented the typical blood product
requirement to produce near-normal postoperative coagu-
lation parameters. To facilitate clinical management and
blood-bank planning, we have separately reported intra-
operative and postoperative blood product use in ruptured
and electively repaired aneurysms. For accurate interpreta-
tion of results and to avoid bias, we think that it is critical
that studies of blood product requirements and transfu-
sion strategies include details of the postoperative period.
To our knowledge, such data for TAAAs repaired without
the use of a cell-saver device are not available. Our results
are comparable with the intraoperative results reported by
Svensson and Crawford,12 with an autotransfusion device:
15 units of PRCs, 16 units of FFP, and 20 units of
platelets were used in this series.
Our analysis has focused on total blood products
transfused, much of which is platelets, FFP, and cryopre-
cipitate. The total transfusion is an index of the demand
for a scarce resource and is a marker of the number of
donors to whom patients are exposed. This exposure is
highest for patients with ruptured TAAAs, followed by
patients treated without ANH, and is least in patients
treated with ANH. The parallel regression lines between
groups shown in Fig 2 (ie, no statistically significant dif-
ference in slope of the different regression lines) indicates
that this difference is consistent for any amount of blood
loss. Because the use of coagulation adjuncts was highest
in the ruptured (50%), intermediate in non-ANH (26%),
and lowest in the ANH group (nil), the differences
observed cannot be attributed to the administration of
desmopressin or epsilon-aminocaproic acid. It is possible
that the technique of ANH may be responsible for these
differences; however, other factors such secular improve-
ments in intensive care practices, learning-curve effects for
either the anesthetist or surgeon, or differences in case mix
may be cause. We believe that a randomized controlled
trial of this issue is warranted.
Consistent with our a priori hypothesis, we observed
that group I and IV TAAAs and distal arch aneurysms
received significantly fewer transfusions compared with
group II and III. This information may also facilitate
blood bank planning and has not, to our knowledge, pre-
viously been reported.
CONCLUSIONS
Clinically important disseminated intravascular coagu-
lation is rare in TAAAs. A mild preoperative prolongation
of PTT was identified in patients with aneurysms com-
pared with control subjects. Transfusion of blood prod-
ucts was quantitated for both intraoperative and
postoperative periods and was highest in patients with
ruptured aneurysms, intermediate in patients undergoing
elective procedures treated without ANH, and lowest in
patients undergoing elective procedures treated with
ANH. With the described strategy of aggressive transfu-
sion, postoperative coagulopathy was mild, although dif-
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ferences were still observed between electively repaired
and ruptured aneurysms. Group I, IV, and distal arch
aneurysms were shown to have lower transfusion require-
ments than group II and III.
We thank the anonymous reviewers of an earlier draft
for their insightful comments and suggestions.
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